Familial combined hyperlipidemia is a polygenic trait.
Gill PK, Hegele RA.
Curr Opin Lipidol. 2022 Apr 1;33(2):126-132. doi: 10.1097/MOL.0000000000000796.
Epidemiology and management of hyperlipidemia.
Karr S.
Am J Manag Care. 2017 Jun;23(9 Suppl):S139-S148.
Hyperlipidemia.
Stewart J, McCallin T, Martinez J, Chacko S, Yusuf S.
Pediatr Rev. 2020 Aug;41(8):393-402. doi: 10.1542/pir.2019-0053.
Genetics of Familial Combined Hyperlipidemia (FCHL) Disorder: An Update.
Taghizadeh E, Farahani N, Mardani R, Taheri F, Taghizadeh H, Gheibihayat SM.
Biochem Genet. 2022 Apr;60(2):453-481. doi: 10.1007/s10528-021-10130-2. Epub 2021 Sep 3.
Postprandial Hyperlipidemia: Its Pathophysiology, Diagnosis, Atherogenesis, and Treatments.
Yanai H, Adachi H, Hakoshima M, Katsuyama H.
Int J Mol Sci. 2023 Sep 11;24(18):13942. doi: 10.3390/ijms241813942.
Mechanisms underlying direct actions of hyperlipidemia on myocardium: an updated review.
Yao YS, Li TD, Zeng ZH.
Lipids Health Dis. 2020 Feb 8;19(1):23. doi: 10.1186/s12944-019-1171-8.
Lipoprotein(a) and familial hypercholesterolemia: Partners in crime in heritable hyperlipidemia.
Kamstrup PR.
Atherosclerosis. 2023 Jan;365:25-26. doi: 10.1016/j.atherosclerosis.2022.12.009. Epub 2022 Dec 24.
Combined hyperlipidemia is genetically similar to isolated hypertriglyceridemia.
Gill PK, Dron JS, Berberich AJ, Wang J, McIntyre AD, Cao H, Hegele RA.
J Clin Lipidol. 2021 Jan-Feb;15(1):79-87. doi: 10.1016/j.jacl.2020.11.006. Epub 2020 Nov 24.
Hypertriglyceridaemia: an update.
Wierzbicki AS, Kim EJ, Esan O, Ramachandran R.
J Clin Pathol. 2022 Dec;75(12):798-806. doi: 10.1136/jclinpath-2021-207719. Epub 2022 Jun 16.
Calculating LDL cholesterol in familial combined hyperlipidemia: Out with the old, in with the new?
Martin SS.
Atherosclerosis. 2018 Oct;277:172-174. doi: 10.1016/j.atherosclerosis.2018.07.034. Epub 2018 Jul 27.
